GlobalData on MSN12h
PTC Therapeutics ALS drug fails to meet endpoints as trials shut downNew Jersey-based biopharma, PTC Therapeutics said its Phase II trial of utreloxastat for patients with amyotrophic lateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback